Skip to content
healthcare.dev

Anagrelide

NDC 62135-313, Anagrelide, capsule, from Chartwell RX, LLC.

Product NDC
62135-313
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076683
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-313 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANAGRELIDE HYDROCHLORIDE ANHYDROUS1 mg/1

Pharmacologic classes

Decreased Platelet Production [PE]; Phosphodiesterase 3 Inhibitors [MoA]; Platelet-reducing Agent [EPC]

Package NDCNDC-11Package
62135-313-606213503136060 CAPSULE in 1 BOTTLE (62135-313-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e031dfb3-56e1-4fea-95f2-c2936e2057a0
  • NADAC price for package 62135031360

    GET /v1/drugs/nadac/62135031360

Use it

Look up 62135-313 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-313 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-313. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.